The FDA announced Tuesday that, going forward, COVID-19 vaccines would be approved only for people over age 65 or those at risk for severe infection .

The move will streamline the approach to yearly vaccination for the coronavirus, but 100 million to 200 million people with certain conditions would still be eligible, Food and Drug Administration officials outlined in a New England Journal of Medicine editorial. The U.S. Centers for Disease Control and Prevention (CDC) lists dozens of conditions that can put people at higher risk . About three-quarters of Americans over age 6 months have at least one of them.

The editorial authors, FDA Commissioner Marty Makary and FDA vaccine chief Vinay Prasad , said the current “one size fits all” vaccine policy may no longer be viable. They sa

See Full Page